期刊文献+

双氯芬酸二乙胺凝胶贴剂的药动学 被引量:3

Pharmacokinetics of diclofenac diethylamine gel-matrix patch
原文传递
导出
摘要 目的:研究自制的双氯芬酸二乙胺凝胶贴剂的兔体内的药动学特征。方法:外贴经皮给药,以德国上市贴剂Flector EP-flaster为参比制剂,用HPLC测定不同时间血药浓度,用3P97药动学程序进行处理,计算药动学参数,并对2种制剂在体内的主要药动学参数分别进行t检验。结果:兔透皮给予双氯芬酸二乙胺后的药动学过程符合一室模型,2种贴剂的药动学参数AUC、Cmax、tmax、t1/2(ka)、ka和Lagtime差异无显著性(P>0.05),而t1/2(ke)和ke差异有显著性(P<0.05),CL/F和V/F差异有极显著性(P<0.01)。结论:自制的双氯芬酸二乙胺凝胶贴剂与相应的德国贴剂相比,具有更缓释、长效的作用。 OBJECTIVE To study the pharmacokinetics of diclofenac diethylamine gel-matrix patch on rabbit. METHODS The HPLC was used to assay the plasma concentration of diclofenac diethylamine after the transdermal delivery, and the comparative patch was diclofenac epolamin patch developed and sold in Germany. The data were processed by 3P97 programme, and the pharmacokinetics parameters were calculated and compared by t test. RESULTS The process of the pharmacokineties of diclofenac diethylamine gel-matrix patch on rabbit fitted to the open one compartment model. There was no significant difference (P〉0. 05) between the respective pharmaeokinetics parameters AUC, Cmax t1/2(ka),ka, and Lag time of the two kinds of patches. The significant difference (P〈0.05) shown between the respective t1/2〈ke) and ke, and the extremely significant differ ence (P〈0.01) was revealed between the respective CL/F and V/F. CONCLUSION The dielofenac diethylamine gel matrix patch has prolonged action.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第24期2113-2115,共3页 Chinese Journal of Hospital Pharmacy
关键词 双氯芬酸二乙胺 凝胶贴剂 药动学 高效液相色谱 diclofenac diethylamine gel matrix patch pharmacokinetics HPLC
  • 相关文献

参考文献4

  • 1林佳亮,王庭贤,苏云驰,曾凡波,金晶,王涛.双氯芬酸钠贴剂绝对生物利用度和局部组织药物浓度研究[J].中国药师,2004,7(11):834-836. 被引量:6
  • 2Idkaidek NM, Amidon GL, Smith DE, etal. Determination of the population pharmaeokinetic parametersofsustained release and enteric-coated oral formulations, and the suppository formulation of diclofenac sodium by simultaneous data fitting u sing NONNEM[J]. Biopharmaceutics & Drug Disposition, 1998, 19(3): 169-174.
  • 3Radermaeher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous appli cation in inflammatory and degenerative joint disease [J]. British Journal of Clinical Pharmacology, 1991, 31 (5) : 537- 541.
  • 4Gschwend MH, Martin W, Arnold P, etal. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation[J]. Arzneimittelforschung,2005, 55(7):403-413.

二级参考文献3

共引文献5

同被引文献1970

  • 1郭涛,隋因,党大胜.双氯芬酸钠在大鼠体内药代动力学的研究[J].实用药物与临床,1998,5(4):14-16. 被引量:3
  • 2郑家润.皮肤局部用药的安全性评价[J].中国新药杂志,2005,14(3):257-259. 被引量:8
  • 3施卉,吴超,邱利焱,金一.几种促进剂对双氯芬酸钠离子导入效果的比较[J].中国药学杂志,2006,41(12):921-923. 被引量:4
  • 4王斐,丁雪鹰,高静,高申.透皮促渗剂对吲哚美辛和沙丁胺醇透皮作用的影响[J].第二军医大学学报,2007,28(4):421-424. 被引量:7
  • 5van Ryn J, Pairet M. Selective cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential EJ]. Expert Opin lnvestig Drugs, 1997, 6 (5) : 609-614.
  • 6Zhao LG, Fang L, Xu YN, et al. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers [J]. Eur J Pharm Biopharm, 2008, 69 (1) : 199-213.
  • 7Zhao LG, Fang L, Xu YN, et al. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity [J]. IntJPharm, 2008, 352 (1-2) : 92-103.
  • 8Hai NT, Kim J, Park ES, et al. Formulation and bio- pharmaceutical evaluation of transdermal patch containing benztropine [J]. Int JPharm, 2008, 357 (1-2): 55-60.
  • 9Krishnaiah YS, Satyanarayana V, Karthikeyan RS. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis [J]. J Pharm Pharm Sci, 2002, 5 (2): 123-130.
  • 10Zhao LG, Li Y, Fang L, et al. Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid [J]. Drug Dev lnd Pharm, 2009, 35 (7) : 814-826.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部